OTC · Financial Statements
Poniard Pharmaceuticals, Inc. (PARD) Financial Statements
$0.00
OTC: PARD
Market Cap $150
Overview Financials Dividend Poniard Pharmaceuticals, Inc. most recently reported annual revenue of $0, a net loss of $30.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2006 2007 2008 2009 2010 Revenue $0 $0 $0 $0 $0 Operating Profit $-21.0M $-35.0M $-49.0M $-43.0M $-28.0M Net Profit $-23.0M $-33.0M $-49.0M $-46.0M $-30.0M EPS $-54.80 $-43.20 $-56.40 $-52.40 $-26.40 Op Margin — — — — —
Balance Sheet (USD)
Metric 2006 2007 2008 2009 2010 Total Assets $69.0M $105.0M $84.0M $52.0M $12.0M Total Liabilities $22.0M $16.0M $37.0M $29.0M $3.0M Cash $44.0M $29.0M $44.0M $16.0M $1.0M Borrowings $14.0M $11.0M $25.0M $20.0M $2.0M
Cash Flow (USD)
Metric 2006 2007 2008 2009 2010 Operating Cash Flow $-17.0M $-25.0M $-33.0M $-35.0M $-24.0M Investing Cash Flow $-20.0M $-61.0M $34.0M $1.0M $24.0M Financing Cash Flow $1.0M $0 $0 $0 $0 Net Cash Flow $41.0M $-15.0M $15.0M $-28.0M $-15.0M Free Cash Flow $-23.0M $-30.0M $-34.0M $-36.0M $-24.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.01 FCF Yield -16188666.67% Quick Ratio 3.23 Interest Coverage -12.65 Return 1Y 0.00% Return 3Y -99.00% Return 5Y -99.21%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .